Tech entrepreneur Bryan Johnson is gaining notoriety for his unusual approaches to extending lifespans. “I Edited My DNA On A Secret Island (To Live Forever)” is a YouTube video that Johnson made on his trip to Roatan, Honduras, for an experimental gene therapy procedure.
Follistatin Therapy: Promising Potential, Uncertain Future
Follistatin is the main ingredient in the remedy in question, which is provided by the biohacking startup Minicircle. One protein that controls muscle growth and development is called follistatin. Research indicates that it may potentially contribute to aging. In Minicircle’s gene therapy, a plasmid—a tiny DNA loop—is used to introduce the follistatin genes into cells.
Animal research in its early stages has shown promise. Johnson mentions a study in which mice given follistatin therapy had a 30% longer lifespan. But it’s important to keep in mind that human results from animal research aren’t usually exact replicas. Human follistatin gene therapy safety and long-term effects are still unknown.
Johnson’s Journey: Radical Measures and Rigorous Routine
Johnson seems unfazed while acknowledging the risks. He says the twenty thousand dollar therapy is working already. He believes that by doing so, he has been able to go back five years in time and now only celebrates his birthday every 19 months. Johnson credits his drastic lifestyle changes in addition to the gene therapy for this. He reportedly spends a staggering $2 million annually on a meticulous health regimen. This includes a strict diet, rigorous exercise routines, and a plethora of supplements. While some might find such measures inspiring, others raise concerns about their sustainability and accessibility.
Ethical Concerns and the Future of Gene Editing
Johnson’s quest for longevity has sparked debates about the ethics of human gene editing. Critics argue that such procedures are premature and can lead to unforeseen consequences. Additionally, the high cost of these treatments raises concerns about equity and access. Despite the controversy, Johnson’s story highlights the growing interest in gene editing for therapeutic purposes. As research progresses, scientists are exploring ways to treat and potentially reverse various diseases and conditions. However, careful consideration of safety, ethics, and accessibility will be paramount in navigating this revolutionary field.
Key Takeaways
- Bryan Johnson is undergoing an experimental gene therapy aimed at slowing down aging.
- The treatment involves introducing follistatin genes into cells.
- While early-stage research shows promise, the long-term effects and safety in humans are unknown.
- Johnson’s story raises ethical concerns about human gene editing and accessibility of such treatments.
- Gene editing holds immense potential for therapeutic applications, but careful research and ethical considerations are crucial.pen_spark
Read more: Marketing News, Advertising News, PR and Finance News, Digital News
